Cancer and treatment-related symptoms are associated with mobility disability in women with ovarian cancer: A cross-sectional study

Abstract

Objective To examine the prevalence of symptom-related mobility disability and identify specific symptoms and other factors associated with mobility disability among a national sample of ovarian cancer (OC) survivors. Methods Descriptive, correlational secondary analysis of a National Ovarian Cancer Coalition mailed survey of women with a history of OC (N = 713). We used the Symptom Representation Questionnaire (SRQ), the MD Anderson Symptom Inventory (MDASI) Interference Scale, and medical and demographic information to determine prevalence of symptom-related mobility disability. We constructed a multiple linear regression model to determine the relative contributions of specific symptoms and other factors to mobility disability. Results A majority of the sample (60.0%) reported symptom-related mobility disability. Independent predictors included: > one comorbidity (β = 0.112, p = 0.001), active OC (β = 0.111, p = 0.037), abdominal bloating (β = 0.097, p = 0.006), fatigue (β = 0.314, p < 0.001), lack of appetite (β = 0.072, p = 0.045), numbness/tingling (β = 0.134, p < 0.001), and pain (β = 0.194, p < 0.001). The model explained 41.5% of the variance in symptom-related mobility disability (R2 = 0.415). Unexpectedly, age (β = -0.028, p = .412) and current chemotherapy (β = 0.107, p = 0.118) were not significant predictors. Conclusions Symptom-related mobility disability is common among women with OC and is associated with medical comorbidities, abdominal bloating, fatigue, lack of appetite, numbness/tingling, and pain. Longitudinal research should clarify the relationship of these symptoms to mobility disability and determine whether effective symptom management minimizes disability.

Effects of high-intensity training on the quality of life of cancer patients and survivors: a systematic review with meta-analysis

“…Most of the negative side effects of cancer and its treatments are related to reduced physical functioning, reduced mobility due to surgery or chemotherapy 81 , lymphedema 82 , negative body composition changes as sarcopenia 83 , or osteoporosis 84 . Providing opportunities to mitigate these deleterious effects through HIT is highly important since more than half of all cancer patients develop a mobility disability because of the disease and its treatments’ adverse side-effects 85 .…”

Patient preferences for visualization of longitudinal patient-reported outcomes data

“…Approximately half of adults in the United States are living with at least 1 chronic illness, of which many are associated with adverse symptoms. 1,2 These symptoms may be disease-related, 3 treatment related, 4 or as in the case of those living with human immunodeficiency virus (HIV), related to both. [5][6][7] Developing new and better ways to monitor and manage symptoms is vital to improve quality of life for those with chronic conditions.…”

Effects of High-Intensity Training on the Quality of Life of Cancer Patients and Survivors: A Systematic Review With Meta-Analysis

“…Most of the negative side effects of cancer and its treatments are related to reduced physical functioning, reduced mobility due to surgery or chemotherapy 89 , lymphedema 90 , negative body composition changes as sarcopenia 91 , or osteoporosis 92 . Providing opportunities to increase independence through HIT is highly important since more than half of all cancer patients develop a mobility disability because of the disease and its treatments' adverse side-effects 93 .…”